Childhood encephalopathies and myopathies: A prospective study in a defined population to assess the frequency of mitochondrial disorders

Pediatrics

Volumn 105, Issue 3, 2000, Pages 598-603

  Uusimaa, Johanna ^a   Remes, Anne M ^a   Rantala, Heikki ^a   Vainionpää, Leena ^a   Herva, Riitta ^a   Vuopala, Katri ^a,b   Nuutinen, Matti ^a   Majamaa, Kari ^a   Hassinen, Ilmo E ^a  

^a UNIVERSITY OF OULU   (Finland)

^b LAPLAND CENTRAL HOSPITAL   (Finland)

Author keywords

Children; Encephalomyopathies; MELAS; Mitochondria; Mitochondrial DNA; Mutation; Respiratory chain

Indexed keywords

LACTIC ACID; MITOCHONDRIAL DNA; MITOCHONDRIAL ENZYME;

ARTICLE; ATAXIA; CHILD; CLINICAL FEATURE; CONTROLLED STUDY; ELECTRON MICROSCOPY; ENCEPHALOMYOPATHY; ENZYME ACTIVITY; EPILEPSY; FEMALE; FINLAND; GENE MUTATION; HISTOCHEMISTRY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MELAS SYNDROME; MENTAL DEFICIENCY; MUSCLE BIOPSY; MUSCLE HYPOTONIA; OXIDATIVE PHOSPHORYLATION; OXIMETRY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PSYCHOMOTOR RETARDATION; RESPIRATORY CHAIN; SPASTICITY; SPECTROPHOTOMETRY;

EID: 0034058869     PISSN: 00314005     EISSN: None     Source Type: Journal    
DOI: 10.1542/peds.105.3.598     Document Type: Article

References (35)

1. Johns DR. Mitochondrial DNA and disease. N Engl J Med. 1995;333: 638-644
2. Tulinius M, Holme E, Kristiansson B, et al. Mitochondrial encephalomyopathies in childhood. I. Biochemical and morphological investigations. J Pediatr. 1991;119:242-250
3. Shoffner JM. Maternal inheritance and the evaluation of oxidative phosphorylation diseases. Lancet. 1996;348:1283-1288
4. (UUR) gene associated with the MELAS subgroup of mitochondrial encephalomyopathies. Nature. 1990;348:651-653
5. Shoffner JM, Lott MT, Lezza AMS, Sabel S, Ballinger SW, Wallace DC. Myoclonic epilepsy and ragged red fiber disease (MERFF) is associated with a mitochondrial DNA tRNALys mutation. Cell. 1990;61:931-937
6. Holt IJ, Harding AE, Petty RKH, Morgan-Hughes JA. A new mitochondrial disease associated with mitochondrial DNA heteroplasmy. Am J Hum Genet. 1990;46:428-433
7. Tatuch Y, Christodoulou J, Feigenbaum A, et al. Heteroplasmic mtDNA mutation (T-G) at 8993 can cause Leigh disease where the percentage of abnormal mtDNA is high. Am J Hum Genet. 1992;50:852-858
8. Holt IJ, Harding AE, Morgan-Hughes JA. Deletions of muscle mitochondrial DNA in patients with mitochondrial myopathies. Nature. 1988;331:717-719
9. Poulton J, Deadman ME, Gardiner RM. Duplications of mitochondrial DNA in mitochondrial myopathy. Lancet. 1989;1:1236-239
10. Tritscher H-J, Andreetta F, Moraes CT, et al. Mitochondrial myopathy of childhood associated with depletion of mitochondrial DNA. Neurology. 1992;42:209-217
11. NAWH National Research and Development Centre for Welfare and Health. Overview on the population's health situation: use of health services and resources. In: Health, II. Gummerus Kirjapaino Oy, Jyväskylä; 1994
12. Durrieu G, Letellier T, Antoch J, et al. Identification of mitochondrial deficiency using principal component analysis. Mol Cell Biochem. 1997; 174:149-156
13. Makinen M, Lee C-P. Biochemical studies of skeletal muscle mitochondria. I. Microanalysis of cytochrome content, oxidative and phosphorylative activities of mammalian skeletal muscle mitochondria. Arch Biochem Biophys. 1968;126:75-82
14. Vuokila FT, Hassinen IE. N′N-Dicyclohexylcarbodi-imide-sensitivity of bovine heart mitochondrial NADH:ubiquinone oxidoreductase. Biochem J. 1988;249:339-344
15. Sottocasa GL, Kuylenstierna BO, Ernster L, Bergstrand A. An electron transport system associated with outer membrane of liver mitochondria: a biochemical and morphological study. J Cell Biol. 1967; 32:415-438
16. Cooperstein SJ, Lazarow A. A microspectrophotometric method for the determination of cytochrome oxidase. J Biol Chem. 1951;89:665-670
17. Schapira AH, Cooper JM, Morgan-Hughes JA, et al. Molecular basis of mitochondrial myopathies: polypeptide analysis in complex I deficiency. Lancet. 1988;1:500-503
18. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein using the principle of protein-dye binding. Ann Biochem. 1976;72:248-254
19. (UUR) gene in MELAS (mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes). Biochem Biophys Res Commun. 1990;173:816-882
20. Zeviani M, Gellera C, Antozzi C, et al. Maternally inherited myopathy and cardiomyopathy: association with mutation in mitochondrial DNA, tRNA Leu. Lancet. 1991;338:143-147
21. Oldfors A, Larsson NG, Lindbery C, et al. Mitochondrial DNA deletions in inclusion body myositis. Brain. 1993;116:325-336
22. Molnar M, Schröder JM. Pleomorphic mitochondrial and different filamentous inclusions in inflammatory myopathies associated with mtDNA deletions. Acta Neuropathol (Berl). 1998;96:41-51
23. Munnich A, Rötig A, Chretien D, et al. Clinical presentation of mitochondrial disorders in childhood. J Inherit Metab Dis. 1996;19:521-527
24. Zeviani M, Bertagnolio B, Uziel G. Neurological presentations of mitochondrial diseases. J Inherit Metab Dis. 1996;19:504-520
25. Lefai E, Terrier-Cayre A, Vincent A, et al. Enzymatic activities of mitochondrial respiratory complexes from children muscular biopsies: age related evolutions. Biochem Biophys Acta. 1995;1228:43-50
26. Morgan-Hughes JA, Schapira AHV, Cooper JM, Clark JB. Molecular defects of NADH-ubiquinone oxidoreductase (complex I) in mitochondrial diseases. J Bioenerg Biomembr. 1988;20:365-380
27. Koga Y, Nonaka I, Kobayashi M, Tojyo M, Nihei K. Findings in muscle in complex I (NADH coenzyme Q reductase) deficiency. Ann Neurol. 1988;24:749-756
28. Morris AAM, Leonard JV, Brown GK, et al. Deficiency of respiratory chain complex I is a common cause of Leigh disease. Ann Neurol. 1996;40:25-30
29. Rahman S, Blok RB, Dahl H-HM, et al Leigh syndrome: clinical features and biochemical and DNA abnormalities. Ann Neurol. 1996;39:343-351
30. Kadowaki T, Kadowaki H, Mori Y, et al. A subtype of diabetes mellitus associated with a mutation of mitochondrial DNA. N Engl J Med. 1994;330:962-968
31. Majamaa K, Turkka J, Kärppä M, Winqvist S, Hassinen IE. The common MELAS mutation A3243G in mitochondrial DNA among young patients with an occipital infarct. Neurology. 1997;49:1331-1334
32. Majamaa K, Moilanen JS, Uimonen S, et al. Epidemiology of A3243G, the mutation for mitochondrial encephalomyopathy, lactic acidosis, and strokelike episodes: prevalence of the mutation in an adult population. Am J Hum Genet. 1998;63:447-454
33. Goto Y, Horai S, Matsuoka T, et al. Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS): a correlative study of the clinical features and mitochondrial DNA mutation. Neurology. 1992;42:545-550
34. Ciafaloni E, Ricci E, Shanske S, et al. MELAS: clinical features, biochemistry, and molecular genetics. Ann Neurol. 1992;31:391-398
35. Dunbar DR, Moonie PA, Zeviani M, Holt IJ. Complex I deficiency is associated with 3243G:C mitochondrial DNA in osteosarcoma cell cybrids. Hum Mol Genet. 1996;5:123-129